Theravance Biopharma to Participate in an Upcoming Investor Conference Apr 10, 2023 06:00AM
Theravance (TBPH) in Better Position Post Trelegy Deal, ampreloxetine Program Remains Key - Needham & Company Maintains Hold Jul 14, 2022 06:37AM
Needham & Company Maintains Hold Rating on Theravance Biopharma (TBPH), Analyst Sees no Meaningful Catalysts in 2022, Awaits Pipeline Progression May 6, 2022 06:49AM
Theravance Biopharma to Participate in an Upcoming Investor Conference Apr 6, 2022 06:00AM
Needham & Company Downgrades Theravance Biopharma (TBPH) to Hold, Following Strategic Business Update Sep 15, 2021 02:28PM


Aug 24, 2021 06:24AM Theravance Biopharma (TBPH) PT Lowered to $18 at Needham & Company
Feb 12, 2020 05:52AM Theravance Biopharma (TBPH) Prices 5.5M Share Common Offering at $27/Sh
Feb 11, 2020 11:05PM Theravance Biopharma Announces Pricing of Public Offering of Ordinary Shares
Apr 2, 2019 08:30AM Theravance Biopharma to Present at the 18th Annual Needham Healthcare Conference
Mar 21, 2018 08:30AM Theravance Biopharma to Present at the 17th Annual Needham Healthcare Conference
Mar 28, 2017 08:30AM Theravance Biopharma to Present at the 16th Annual Needham Healthcare Conference
Feb 28, 2017 07:07AM Needham & Company Reiterates Buy on Theravance Biopharma (TBPH) Following Conference Call
Dec 21, 2016 06:48AM Needham & Company Starts Theravance Biopharma (TBPH) at Buy
Oct 28, 2016 08:59AM Theravance Biopharma (TBPH) Prices 3.85M Shares, $200M Conv. Notes Offerings
Oct 28, 2016 02:13AM Theravance Biopharma Announces Pricing of Public Offerings of 3,850,000 Ordinary Shares and $200 Million of 3.25% Convertible Senior Notes due 2023
Oct 26, 2016 04:38PM Theravance Biopharma (TBPH) Announces $100M Shares, $150M Conv. Stock Offerings
Oct 26, 2016 04:20PM Theravance Biopharma Announces Proposed Public Offerings of $100 Million of Ordinary Shares and $150 Million of Convertible Senior Notes
Apr 7, 2016 04:30PM Theravance Biopharma to Present at 15th Annual Needham Health Care Conference
Apr 7, 2015 04:15PM Theravance Biopharma to Present at the Needham Healthcare Conference